Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Controlled, Single Blinded, Study to Evaluate the Safety and Effectiveness of Bioseal as an Adjunct to Sutured Dural Repair

NCT03110783 is registered in ClinicalTrials.gov with Guangzhou Bioseal Biotechnology Co., Ltd. as lead sponsor.

NCT NCT03110783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03110783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Controlled, Single Blinded, Study to Evaluate the Safety and Effectiveness of Bioseal as an Adjunct to Sutured Dural Repair
Lead sponsor
Guangzhou Bioseal Biotechnology Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
September 14, 2017
Completion date
September 20, 2019
Enrollment
200 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

benign tumors, malignant tumors, vascular malformation